Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
City of Hope Medical Center
MacroGenics
Incyte Corporation
Incyte Corporation
Xencor, Inc.
Stanford University
Eli Lilly and Company
AstraZeneca
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Celldex Therapeutics
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Canadian Cancer Trials Group
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Scripps Health
Ludwig Institute for Cancer Research
Incyte Corporation
Pfizer
Incyte Corporation
Five Prime Therapeutics, Inc.
MacroGenics
Incyte Corporation
Incyte Corporation
Gilead Sciences
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Celgene
City of Hope Medical Center
Mayo Clinic
Swiss Cancer Institute
Kantonsspital Winterthur KSW
University of Alabama at Birmingham
Celldex Therapeutics
University of Kansas Medical Center
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Novartis
M.D. Anderson Cancer Center
University of Southern California
Fox Chase Cancer Center
National Cancer Institute (NCI)